Skip to main content

The Importance of Mental Health in the Workplace

The crises and challenges of the pandemic have put mental health in the spotlight for employers, and 2022 should remain a critical time for workplace mental health. Employees aren’t getting a mental break as the pandemic evolves. Employers continue to work on ways to address short- and long-term mental health issues as their employees live through the pandemic. Fortunately, the mental burden of the COVID-19 pandemic has enabled more transparency and empathy around the topic, especially in the workplace.

So, what is mental health? An employee’s mental health includes how they think, feel and act, and it includes their emotional and social well-being. While mental health includes mental illness, the two aren’t interchangeable. An employee can go through a period of poor mental health but not necessarily have an evident, diagnosable mental illness. Additionally, an employee’s mental health can change over time, depending on their workload, stress and work-life balance. Employers should be invested in their employees’ mental health because healthy employees are absent less, contribute to a positive workplace culture and are more productive.

What Can Employers Do?
  • Promote mental health awareness in the office.
  • Offer flexible scheduling.
  • Address workplace stress.
  • Evaluate benefits offerings.
  • Train managers.

Download the HR Edge Q4 2021 Newsletter for more information on the importance of mental health in the workplace, and also understand why employees stay or leave and ways that employers are integrating tech into HR.

For more human resources trends, industry insights and proactive strategies to maintain a competitive edge in today’s workplace, contact HANYS Benefit Services by email or by calling 518.431.7735.

This is not intended to be exhaustive nor should any discussion or opinions be construed as professional advice. © 2021 Zywave, Inc. All rights reserved.

Popular posts from this blog

SECURE 2.0 Discussion Series: Session Two

The retirement industry has been buzzing since the SECURE 2.0 Act was signed into law last December. This new, comprehensive legislation has sparked a lot of discussion. As with any major reform, it will take time for the industry to fully adapt and understand all its implications. Following our April 11 webinar on the first three months of the industry’s response, our team reconvened to discuss some of what we have heard from our client and vendor partners and to respond to some of the great questions we heard from attendees. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. The Discussion SB – Throughout the webinar, I wanted to stress two things: 1) confusion about where to start and what is expected from plan sponsors is normal; and 2) even more than three months in, this is a developing situation and people should expect changes as time goes on. With those in mind, engagement through

SECURE 2.0 Discussion Series: Session One

SECURE 2.0 provisions: What we know and what’s still up in the air The SECURE 2.0 Act, signed into law in late December 2022, has factored heavily in retirement industry discourse since the final legislation was published. As with any legislation of this depth and breadth, there’s a lot to digest and the industry takes time to adjust. Our team of experienced advisors recently met to discuss some of the more nuanced provisions of the legislation, such as changes to Roth contributions, and what they could mean for plan sponsors. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. Highlights of our panel’s conversation below should serve to help guide plan sponsor thinking. On Roth employer contributions NB – In addition to deferring pre-tax or Roth, plan sponsors can now allow employer contributions to be classified as Roth, is that right? VB – Correct. This is immediately available to plan s

What you should know about biosimilars

Rapidly increasing healthcare costs will likely continue to impact employers for the foreseeable future. As a result, many employers are considering strategies to manage these costs, including rising prescription drug costs. The introduction of biosimilar drugs as an alternative to biologics may bring value to healthcare by offering cost savings and increasing employee access to necessary medications. While biosimilars can potentially combat rising prescription drug costs, employers will need to learn more about them before considering how their health plans can accommodate these newer drugs. This article explores biosimilar drugs and ways employers can promote or manage their use. What are biosimilars? The European Medicines Agency defines a biosimilar as “a biological medicine highly similar to another already approved biological medicine.” It is produced from living organisms — humans, animals or microorganisms, meaning they aren’t created from synthesized chemicals. They are also